Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
about
Surgery for Dupuytren's contracture of the fingersSurgery for Dupuytren's contractures of the fingersNoninflammatory Joint Contractures Arising from Immobility: Animal Models to Future TreatmentsAnti-TNF therapy: past, present and futureStructural Comparison of ColH and ColG Collagen-Binding Domains from Clostridium histolyticumImmunity, Inflammation, and CancerWhat are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practiceConnective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease)In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related propertiesTrends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modelingNonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study.Difference in Success Treating Proximal Interphalangeal and Metacarpophalangeal Joints with Collagenase: Results of 208 TreatmentsReversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.Dupuytren's Disease: Review of the Current Literature.Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory studyLate complications of clinical clostridium histolyticum collagenase use in Dupuytren's diseasePostapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 daysAnti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblastsGenome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's diseasePrevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based studyUse of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.Cloning of a novel collagenase gene from the gram-negative bacterium Grimontia (Vibrio) hollisae 1706B and its efficient expression in Brevibacillus choshinensisNight-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial.Structures of three polycystic kidney disease-like domains from Clostridium histolyticum collagenases ColG and ColH.Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic ratClinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contractureModulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectorsClinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese PatientsAssessment of potential cross-reactivity of human endogenous matrix metalloproteinases with collagenase Clostridium histolyticum antibodies in human sera obtained from patients with Dupuytren's contracture.Modified percutaneous needle aponeurotomy for the treatment of dupuytren's contracture: early results and complications.Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.Minimally invasive partial fasciectomy for Dupuytren's contractures.Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol.
P2860
Q24187166-D765E218-2F97-405F-8FA0-615D3F317A4DQ24200236-E47C715B-E5CA-479D-B4B3-D38441C29345Q26801592-3D8856F0-8E6B-473E-893B-86CCC6B55865Q26997311-A18D0973-FA6F-47E4-A3C6-7C3EF6C79C5BQ27675085-A8AC008C-E5CA-4613-A035-46A92C347869Q27861048-407C35F0-9E6D-4B4F-9083-E132D368A6C9Q28067091-9AAA9FD1-25B4-43A6-AA17-7739CF842148Q28070387-B61D03C8-8F51-4B1B-9556-331C78B22D35Q28481259-99D34B1E-12C9-4B9B-AA0D-E57D8445403CQ30275011-A1452397-5CB3-4491-9C6F-81B42C4EE8FDQ30597451-F28319BC-4612-4E85-B34F-1344859639EDQ30639252-7266EB8F-DF8A-473A-B2B3-F035EE212839Q33353493-9BAC5451-47D2-4A22-A1AA-9A23086B4CE7Q33619753-BD205417-5AAA-4E3F-B1C5-26DC480F3F1AQ33664757-CE107C04-9098-462D-A3E2-CD0B5817AAF3Q33911834-595A7949-1168-4FBB-B34F-124D4700CCE9Q34153159-68057CC5-68E0-41E3-9ED4-01BD7912F9C2Q34212977-5C2A77F7-31AE-42C7-B05F-86A321D66001Q34249633-42AB057D-0391-40ED-ABCC-5D2940CA3A23Q34389581-DAAEAE3A-5597-400C-9908-E512F3272675Q34534536-C2069263-AF43-4B45-A91E-EBB112D41675Q34544470-39DE4D3B-5413-4DA8-8E59-BD5BAF100BD3Q34648643-C9C925FE-271E-45D3-8E24-D2EC28513EFCQ34975787-464705EC-CD25-44D9-9282-DD4EA8AA9EA1Q35017315-6ACA6D26-F112-4653-958D-5923B37B4922Q35096207-FE838169-F0C2-4E62-841B-0EBB56781392Q35137482-95D10461-4581-43B8-AE32-4663C146C232Q35167677-0CDE11ED-BFD0-429E-AD37-CCF88C9996BCQ35181805-3252B2FA-F485-4F62-AA81-D8D0A6AD7343Q35645333-F3E52FD4-6E00-4282-ABBD-D5FF21D61783Q35655476-1D38612C-8097-4258-B4F3-C593A0DF1409Q35661449-2E08C5D7-9850-438E-B99F-0B0817E3E676Q35672938-062D93EE-212C-476B-95B1-7A317902A201Q35687675-B5049C61-5E4B-4B07-A49A-5E0DB7DE69A4Q35867209-35C533D5-E7C7-4FBD-BD20-0E31B0F55BF0Q36001699-EB961AEC-B033-4793-880A-CBE14AE96768Q36001782-C36F4030-C465-4662-AE4F-52F9A5C7836CQ36134941-95D0D827-8E4F-42B2-AE03-FF63BA438AFEQ36427744-3864DD28-954D-44B4-A9E6-8BDD0C8CC341Q36653340-77A401FF-3124-4446-B385-CB25F6E87429
P2860
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@ast
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@en
type
label
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@ast
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@en
prefLabel
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@ast
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@en
P2093
P356
P1476
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
@en
P2093
CORD I Study Group
F Thomas D Kaplan
John Rodzvilla
Lawrence C Hurst
Marie A Badalamente
Robert N Hotchkiss
Roy A Meals
Theodore M Smith
Vincent R Hentz
P304
P356
10.1056/NEJMOA0810866
P407
P577
2009-09-01T00:00:00Z